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ABSTRACT 9 
Red light has been shown to provide neuroprotective effects. Axotomising the optic nerve 10 
initiates retinal ganglion cell (RGC) degeneration, and an early marker of this is dendritic 11 
pruning. We hypothesised that 670 nm light can delay axotomy induced dendritic pruning in 12 
the retinal explant. To test this hypothesis, we monitored the effects of 670 nm light (radiant 13 
exposure of 31.7 J/cm2), on RGC dendritic pruning in retinal explants from C57BL/6J mice, at 14 
40 minutes, 8 hours and 16 hours post axotomy. For sham-treated retinae, area under the Sholl 15 
curve, peak of the Sholl curve and dendritic length at 8 hours post axotomy showed 16 
statistically significant reductions by 42.3% (p=0.008), 29.8% (p=0.007) and 38.4% (p=0.038), 17 
respectively, which were further reduced after 16 hours by 40.56% (p<0.008), 33.9% 18 
(p<0.007), 45.43% (p<0.006), respectively. Dendritic field area was also significantly reduced 19 
after 16 hours, by 44.23% (p<0.019). Such statistically significant reductions were not seen in 20 
light-treated RGCs at 8 or 16 hours post axotomy. The results demonstrate the ability of 670 21 
nm light to partially prevent ex vivo dendropathy in the mouse retina, suggesting that it is 22 
worth exploring as a treatment option for dendropathy associated neurodegenerative diseases, 23 
including glaucoma and Alzheimer’s disease.  24 
25 
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INTRODUCTION  26 
Evidence is continually mounting in support of the potential of red and near infrared (NIR) 27 
light therapy to provide protective effects in various neurodegenerative diseases including 28 
Parkinson’s disease and multiple sclerosis [1-3]. Red/NIR light therapy has also shown great 29 
potential in the treatment of the more acute neurodegenerative conditions such as stroke, spinal 30 
cord injury and traumatic brain injury [1, 4-11]. 31 
Since longer wavelengths have the ability to penetrate deeper than shorter wavelengths, NIR 32 
light is the preferred choice for irradiating brain tissue [12]. When irradiating the retina 33 
however the issue of tissue penetration, when using shorter wavelengths, is avoided. 34 
Consequently, the beneficial effects of red light have been reported in the retina. Treatment 35 
with 670 nm light has provided protection against cell loss in various rodent models of 36 
photoreceptor damage whilst demonstrating the safety of using 670 nm light with an irradiance 37 
of 60 mW/cm2 on this light sensitive tissue [13, 14]. Also, 670 nm light provided protection in 38 
other models retinal damage or dysfunction [15-18]. In particular, treatment with 670 nm light 39 
in a rat model of partial axotomy (optic nerve transection) resulted in improved vision, 7 days 40 
post injury [19].   41 
Apoptosis, the primary mechanism of retinal ganglion cell (RGC) death following axotomy, 42 
has been shown to be delayed until 3-4 days after axotomy, in vivo [20]. RCG dendritic 43 
pruning, as characterized by a reduction in dendritic complexity, reduced dendritic arbor area 44 
and shrinkage of dendrites, has been observed in mouse models of both glaucoma and 45 
Alzheimer’s disease and this event has been suggested to precede cell loss [21-23].   46 
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Until recently, the mechanisms by which dendrites are eliminated from the neuron were largely 47 
unknown. Newly emerging data has provided some mechanistic insight into this process. The 48 
findings of one such study has suggested that dendrite degeneration occurs in a process 49 
independent of apoptosis involving a local loss of mitochondrial membrane potential and ATP 50 
decline, which precede dendrite loss [24]. Inflammation is, likewise, thought to play a 51 
prominent role in this process, as an increase in the pro-inflammatory cytokine, interferon γ, 52 
and an upregulation in complement proteins were found to be associated with the dendritic 53 
pruning that occurs in neurodegenerative diseases and neural injury [25, 26]. Other findings 54 
have shown the inhibition of mTOR, the key signal integrator for a variety of extracellular 55 
signals including growth factors, to be involved in dendritic pruning [27]. Notably, cellular 56 
stressors such as low ATP levels and inflammation have been shown to inhibit mTOR, and 57 
optic nerve lesion has been shown to bring about the inhibition of an mTOR complex, an event 58 
which has been shown to coincide with dendritic retraction.  59 
Red/NIR light, which is absorbed by complex IV of the mitochondrial electron transport chain, 60 
has been shown to upregulate the enzymatic activity of complex IV, increase the mitochondrial 61 
membrane potential and increase ATP production [28-34]. Red light was also found to have an 62 
anti-inflammatory effect as markers of inflammation, including complement proteins, were 63 
significantly reduced in the outer retina following 670 nm light treatment [30, 31, 35-37]. 64 
Additionally, red/NIR light was found to modify cell growth by modulating the Akt/mTOR 65 
signaling pathway in cancer cells [38]. In fact, the PI3K/Akt/mTOR pathway, which is 66 
involved with cell growth, proliferation, differentiation and survival, has been reported to be 67 
one of the most studied pathways that is influenced by red/NIR light [39]. 68 
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Clearly, many of the mechanisms proposed to be involved in the dendritic pruning process are 69 
potential therapeutic targets of the molecular mechanism responsible for the beneficial effects 70 
of 670 nm light. Therefore, we have hypothesised that 670 nm light can delay the dendritic 71 
pruning that is initiated upon axotomy. To test this hypothesis we used an ex vivo model of 72 
dendritic pruning in the mouse retinal explant. Explanting the retina which involves axotomy 73 
of the entire population of RGCs by complete severing of their axons, is rapidly followed by 74 
pruning of the RGC dendrites [27]. The retinal explant, consequently, provides a platform 75 
upon which to test the effects of 670 nm light on dendritic pruning in a substantially shorter 76 
timeframe than would be possible in the aforementioned models of RGC degeneration. The 77 
effect of 670 nm light on the RGC dendritic pruning in the retinal explant was monitored at 40 78 
minutes, 8 hours and 16 hours post axotomy. Changes in RGC dendritic morphology over time 79 
were investigated by employing various methods to analyze dendritic complexity, including 80 
Sholl analysis, area under the Sholl curve, the maximum peak of the Sholl curve, average total 81 
dendritic length and average dendritic field area. 82 
MATERIALS AND METHODS 83 
Animals used: Twenty five wild-type, 9 week old, male C57 BL/6J mice were used as the 84 
source of retinal explants. Each mouse contributed a maximum of one retina per experimental 85 
condition. 86 
Mice were kept in a 12 hour light (4.88 lux of warm white fluorescent lighting with an 87 
irradiance of 0.7 µW/cm2) / 12 hour light-dark cycle with food and water available ad libitum. 88 
Maintenance and all experimental procedures were in compliance with the ARVO Statement 89 
 6 
for the Use of Animals in Ophthalmic and Vision Research and were approved by the Home 90 
Office, UK. 91 
Red light treatment: Mice were killed by cervical dislocation under 275 lux of warm white 92 
fluorescent light (providing total irradiance of 74 µW/ cm2 and an irradiance of 2.8 µW/cm2 in 93 
the 600-780 nm range of the electromagnetic spectrum). Retinae were then dissected under 676 94 
lux of warm white fluorescent light (providing a total irradiance of 250 µW/ cm2 and an 95 
irradiance of 130 µW/cm2 in the red range). Retinae were dissected as described previously and 96 
flat mounted onto a 0.4 µm pore PTFE membrane culture plate insert [40]. One retina per 97 
mouse was assigned to sham treatment and the other to light treatment. The insert was placed 98 
in a 6-well plate containing pre-warmed Neurobasal A media (Invitrogen) at 37 °C. 99 
Red light was delivered to the retinae from a WARP 10 light source (Quantum devices, Inc., 100 
Wisconsin, USA), immediately after flat mounting. Red light-treated retinae were exposed to 101 
670 ±15 nm (half width half maximum, HWHM) light with a fluence of 31.7 J/cm², delivered 102 
by 6 sequential 88 second exposures of the WARP 10 light device, over a 10 minute period, at 103 
room temperature (see Supplementary Materials). Sham treated retinae were placed, at room 104 
temperature, in a separate room to the light treatment. Upon cessation of the treatment, the 105 
retinae were labelled using DiOlistics, either immediately or after an ex vivo period of 8 or 16 106 
hours in a dark incubator, at 37 °C. 107 
DiOlistic labelling of retinal ganglion cells: Retinal ganglion cells were labelled with 108 
lipophilic fluorescent dyes to facilitate imaging of the RGC soma, dendrites and axon. 1,10-109 
dioleyl-3,3,3,3 tetramethylindocarbocyanine methanesulphonate (DiO) (Invitrogen) or 110 
3,3’dihexadecyloxacarbocyanine perchlorate (DiI) coated tungsten particles were prepared 111 
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prior to retinal preparation, as described previously [40], which was modified from the original 112 
protocol [41]. DiOlistic labelling of retinal ganglion cells and the preparation of retinae for 113 
imaging was described previously [40]. Retinae were shot once at 100 psi using a Helios gene 114 
gun (Bio-Rad) 3 cm from the retina through a 3 µm pore size, high pore density cell culture 115 
insert (Milipore), to deliver the dye coated particles to the RGCs. After DiOlistic labelling the 116 
explants were transferred to a 5% CO2 incubator at 37 °C for 30 minutes, to facilitate diffusion 117 
of the dye throughout the cells. The retinae were fixed with 4% paraformaldehyde before 118 
staining with TO-PRO nuclear stain. The retinae examined in the initial, second and third time 119 
points were fixed 40 minutes, 8 hours and 16 hours, respectively, post axotomy. 120 
Analysis of RGC dendritic complexity: RGC images were acquired with a Zeiss LSM 121 
510 confocal microscope (Carl Zeiss, Ltd, UK), using a 20X (0.8 NA) objective lens, 543 nm 122 
excitation and BP 565-615 nm emission filter for DiI, 488 nm excitation and BP 500-530 nm 123 
emission filter for DiO and 633 excitation and 651-704 nm emission spectral window for TO-124 
PRO.  125 
Images stacks were collected each 1 µm distance along the Z-plane, from the ganglion cell 126 
layer to the inner nuclear layer, producing a reconstructed 3-dimensional image. The 127 
experimental groups to which the cells belonged to were masked using a Fiji plugin prior to 128 
tracing [42]. Dendrites were traced using the Fiji plugin Simple Neurite Tracer [43], to 129 
facilitate Sholl analysis using the automated Sholl analysis Fiji plugin. Sholl analysis [44] 130 
quantitatively measures dendritic complexity, counting the number of dendritic intersections 131 
with concentric rings placed at 10 µm intervals from the soma centre to the most peripheral 132 
dendrite.  133 
 8 
To facilitate statistical comparison, obtaining the area under the Sholl curve for individual 134 
RGCs was required. The area under the Sholl curve was obtained by integration of the area 135 
under a 5 parameter Weibull curve fitted to the Sholl data of individual cells in Sigma Plot 136 
using the following equation:  137 
 138 
Where a, b, c, x0, y0 are the fitted parameters, y is the number of intersections of dendrites with 139 
concentric rings placed at 10 µm intervals from the soma centre to the most peripheral dendrite 140 
and x is the distance from the RGC soma centre.  141 
The total dendritic length was calculated from the sum of lengths of each dendritic path 142 
measured in Simple Neurite Tracer plugin of Fiji.  The dendritic field area of the RGC was 143 
obtained by connecting the ends of each dendrite using a polygon tool in Fiji.  144 
Statistical analyses: The Shapiro-Wilk test was performed in SPSS to test for normality in 145 
the data. Non-parametric data were analysed using a Mann-Whitney U test in SPSS. p values 146 
less of than 0.05 were considered statistically significant. 147 
  148 
RESULTS 149 
A total of 31 retinae out of 50 included RGCs with fluorescent labeling that allowed for 150 
accurate tracing of their dendrites followed by Sholl analysis (Figure 1).  151 
Sholl analysis is a method used to analyze dendritic morphology, which gives information on 152 
the functionality of the neuron and its ability communicate effectively with other cells [45]. 153 
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Since dendrites are the main regions of information input into neurons, reductions in the 154 
number of dendrites could hinder the ability of the RCG to receive information from the 155 
preceding bipolar and amacrine cells. Changes in dendritic morphology are associated with 156 
malfunction in neurons, as seen in neurodegenerative diseases. Sholl analysis enables the 157 
monitoring of these changes quantitatively by producing the data in the form of a Sholl profile. 158 
 In this experiment, the Sholl profile, which illustrates the number of intersections of dendrites 159 
with concentric rings placed at each 10 µm distance from the cell soma, of RGCs from sham 160 
treated retinae showed a downward and leftward shift after both 8 and 16 hours ex vivo, 161 
indicating a loss of RGC dendritic complexity over time (Figure 1C). In retinae treated with 162 
red light, the leftward shift in the RGC Sholl profile over time was less profound (Figure 1D). 163 
There was a statistically significant reduction in the number of dendritic intersections at 70, 90 164 
and 130 µm from the soma after 8 hours (p<0.05) and at 30 (p<0.05), 40 (p<0.01), 50 165 
(p<0.05), 60-70 (p<0.01) and 80-110 µm (p<0.05) after 16 hours ex vivo for sham-treated 166 
retinae.  In contrast, RGCs from light treated retinae had no statistically significant reductions 167 
in the number of dendritic intersections at any point on the Sholl curve after 8 or 16 hours.  168 
<Figure 1> 169 
 170 
The Sholl profile suggests that there is a difference in the area under the Sholl curve and the 171 
maximum number of dendritic intersections in the Sholl plot. For statistical comparison 172 
however, it was necessary to compare the Sholl profiles of the individual RGCs used to create 173 
the Sholl plots in Figure 1. This was achieved by fitting a curve to the Sholl plot of each cell 174 
and doing subsequent analysis using the entire population of neurons, allowing statistical 175 
comparisons to be made. 176 
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A 5 parameter Weibull curve, fitted to each RGC, enabled the calculation of the average area 177 
under the fitted curves and the average peak of the fitted curves for each experimental group 178 
(Figure 2A). The average area under the fitted Sholl curves, of RGCs from sham treated retinae 179 
was reduced from 2042 a.u. at 40 minutes to 1177 a.u. after 8 hours ex vivo (p=0.008) and to 180 
1213 a.u. after 16 hours (p=0.016) (Figure 2B). For light-treated retinae the values were 181 
reduced from 2186 a.u. after 40 minutes to 1804 a.u. after 8 hours and to 1706 a.u. after 16 182 
hours but none of the differences were significant (p=0.561 and p=0.232, respectively) (Figure 183 
2B). 184 
The average maximum peak of the fitted curves for RGCs from sham-treated retinae was 185 
significantly reduced from 22.1 intersections at 40 minutes to 15.5 intersections at 8 hours 186 
(p=0.007) and to 14.6 intersections at 16 hours (p=0.007). In RGCs from light-treated retinae, 187 
the average maximum peak of the fitted curves was reduced from 22.1 at 40 minutes to only 188 
20.0 intersections after 8 hours and to 17.3 a.u after 16 hours (p=0.639 and p=0.113, 189 
respectively) (Figure 2C).  190 
<Figure 2> 191 
The fitted curves then underwent additional analyses to explore the initial rate of branching of 192 
the Sholl curve from the soma to the half maximum of the Sholl peak (Figure 3A). The initial 193 
rate of branching provides information on the extent of proximal branching of the RGC 194 
dendritic arbor. The rate of decay of the Sholl curve was also measured to explore the extent of 195 
branching from the peak of the Sholl curve to the half maximum (Figure 3B). This parameter 196 
yields information on the extent of branching occurring in the more distal region of the RGC’s 197 
dendritic arbor.  198 
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In RGCs from sham-treated retinae, there was no statistically significant change in the rate of 199 
growth of the Sholl curve from the soma to the half maximum of the Sholl peak from 40 200 
minutes to 8 hours (0.49 to 0.38, p=0.125) or from 40 minutes to 16 hours (0.49 to 0.52, 201 
p=0.910) indicating that the branching of the most proximal dendrites was not altered up to 16 202 
hours post axotomy. Similarly, changes in the rate of decay of the Sholl curve from the 203 
maximum to the half maximum, in sham-treated retinae, were found not to be statistically 204 
significantly different: 0.27 at 40 minutes, 0.22 after 8 hours (p=0.170 when compared to the 205 
value at 40 minutes) and 0.20 after 16 hours (p=0.052 when compared to the value at 40 206 
minutes) in sham-treated RGCs. 207 
<Figure 3> 208 
To further investigate the effects of red light on RGC dendrites after axotomy, measurements 209 
of dendritic field area and total dendritic length, which are additional measures of RGC 210 
dendritic complexity were obtained. Dendritic field area provides information on how widely 211 
the cell spreads over the retina and relates to the size of its receptive field. Since RGCs are the 212 
final neurons in the visual pathway before the light signal is transmitted to the brain, a 213 
reduction in the area of the RGC dendritic field could diminish photosensitivity, impeding the 214 
entire visual process. Similarly, since total dendritic length has been found to be positively 215 
correlated with whole-neuron capacitance [46], a decrease in this parameter could negatively 216 
impact on the ability of the cell to reach the threshold for electrical stimulation, thereby 217 
reducing the likelihood of an action potential being formed. 218 
The average dendritic field area for RGCs from sham-treated retinae decreased significantly 219 
from 31204 µm2 at 40 minutes to 17402 µm2 after 16 hours ex vivo (p=0.019). Contrastingly, 220 
where retinae were treated with 670 nm light, the RGCs did not experience a statistically 221 
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significant reduction in their average dendritic field area (28971 to 22540 µm2, p=0.195) 222 
(Figure 4B).  223 
A statistically significant decrease in the average total dendritic length was also seen in RGCs 224 
from sham treated retinae, from 3007 µm at 40 minutes to 1851 µm at 8 hours (p=0.038) and 225 
to 1640 µm at 16 hours (p=0.006). The values for dendritic length decreased from 2943 µm to 226 
2430 µm after 8 hours (p=0.286) and 2362 after 16 hours (p=0.170), in RGCs that were 227 
exposed to 670 nm light, but the differences were not statistically significant (Figure 5B). 228 
Although the average total dendritic field area of red light-treated retinae was 30% greater than 229 
in the sham-treated retinae after 16 hours, the difference was not statistically significant 230 
(p=0.385).To determine the number of retinae required to obtain a statistically significant 231 
difference between red light and sham-treated retinae after 16 hours, a sample size calculation 232 
was done. It was determined that 40 additional retinae would be required for the sham-treated 233 
group and 61 for the red light-treated group to achieve a statistically significant difference in 234 
the dendritic field area between sham and red light-treated retinae after 16 hours at 0.8 power. 235 
<Figure 4> 236 
<Figure 5> 237 
In summary, the statistically significant reductions in the number of RGC dendritic 238 
intersections at various points on the Sholl plot were observed after 8 and 16 hours in sham-239 
treated retinae but were not seen in red light-treated retinae. Treatment with red light also 240 
prevented a statistically significant reduction to the area under the Sholl curve and to the peak 241 
of the Sholl curve. The results for average dendritic field area and average total dendritic 242 
length measurements were consistent with Sholl analysis data, showing the ability of 670 nm 243 
light to prevent statistically significant decreases in further parameters of dendritic complexity. 244 
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Red light prevented statistically significant reductions in the total loss of dendrites form the 245 
entire RGC dendritic arbor, the total area of the dendritic field and the loss of dendrites from 246 
the most densely branched region of the RGC dendritic arbor. 247 
 248 
DISCUSSION 249 
Herein we report, for the first time, of the ability of 670 nm light to prevent the dendritic 250 
pruning that occurs upon axonal injury. In this study, we investigated the effect of 670 nm light 251 
on RGC dendritic pruning which occurs in the mouse retinal explant upon axotomy of the 252 
optic nerve. This degeneration was detectable by analysis of dendritic morphology after 8 253 
hours and again after 16 hours, where statistically significant decreases from initial values were 254 
observed in sham-treated explants. Sholl analysis revealed statistically significant reductions in 255 
the number of dendritic intersections at various points of the Sholl curve after both 8 and 16 256 
hours. The area under the Sholl curve, the average peak of the fitted Sholl curve, the average 257 
total dendritic length and average dendritic field area after 16 hours also showed statistically 258 
significant reductions from the values at 40 minutes by 40.56% (p<0.008), 33.9% (p<0.007), 259 
45.43% (p<0.006), and 44.23% (p<0.019), respectively. Our results have demonstrated that 260 
670 nm light can prevent the statistically significant reductions in these measurements up to 16 261 
hours post axotomy, since the reductions seen in RGCs from light treated retinae were smaller 262 
and not statistically significant. The results revealed that rapid intervention with 670 nm light, 263 
when administered immediately after the acute optic nerve lesion, axotomy, prevented 264 
significant neuronal damage.  265 
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Evidence has been gathered, suggestive of a role for dendritic abnormalities in the pathology 266 
associated with the initial clinical symptoms of a range of neurodegenerative diseases [27]. 267 
Degeneration of RGCs is a hallmark of devastating retinal degenerative diseases such as 268 
glaucoma and autosomal dominant optic atrophy (ADOA). A progressive degeneration of the 269 
RGCs in such diseases coincides with deterioration in visual acuity, eventually resulting in 270 
blindness. In experimental glaucoma, dendritic pruning has been suggested to precede selective 271 
loss of RGCs [47-49].  Also in ADOA, dendritic pruning was found to begin at a time when a 272 
loss in visual acuity was observed, in a mouse model of the disease [40].   273 
The effect of changes to the dendritic morphology of neurons has also been observed in some 274 
of the most common and debilitating, neurodegenerative diseases, including Alzheimer’s 275 
disease. In the postmortem brains of Alzheimer’s disease patients, there was a marked decrease 276 
in the number of dendritic branches in the majority of neurons from the visual and acoustic 277 
cortices compared to normal controls [50]. In addition, there was a 45% decrease in the 278 
dendritic field area compared with controls in these neurons. Alterations in dendritic 279 
morphology has also been found in Parkinson’s disease [51].  In the substantia nigra pars 280 
compacta of post mortem tissue from Parkinson’s disease patients, there was a severe 281 
reduction in the dendritic length of dopaminergic type I neurons compared with healthy 282 
controls [52]. Similarly, in post mortem tissue from patients with multiple sclerosis (MS), a 283 
loss in dendritic arborization was observed in cortical lesions [53]. This pathology was thought 284 
to contribute to the clinical symptoms of MS by decreasing the synaptic input to the cortex. 285 
Since these relatively subtle changes to the neurons are thought play a role in the clinical 286 
symptoms, mild beneficial effect on the survival ability of the dendrites could translate into a 287 
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significant clinical effect. Delaying the dendritic pruning that occurs in the early stages of these 288 
neurodegenerative diseases could delay the onset of clinical symptoms, thereby providing an 289 
invaluable improvement to the quality of life of patients.  290 
The pathology for the initial symptoms in the discussed diseases appears to be due to a loss of 291 
dendrites as opposed to cell death. Moreover, dendritic degeneration appears to occur via a 292 
process independent of neuronal loss. It was found that the inhibition of pro-apoptotic proteins 293 
was sufficient to delay neuronal somal death while failing to have any preventative effect on 294 
dendritic pruning [54]. Therefore, looking at ways of preventing dendritic pruning may require 295 
a unique approach and may also be a more fruitful treatment strategy than merely endeavoring 296 
to keep dysfunctional cells alive. 297 
Our understanding of the pathology of neurodegenerative diseases seems to be changing from 298 
one of progressive cell loss to one whereby more subtle alterations in the dendritic morphology 299 
are associated with the initial clinical symptoms. The alterations to the dendritic morphology 300 
reported in the aforesaid neurodegenerative diseases were similar to those changes observed in 301 
the current experiment after 16 hours post axotomy, in the retinal explant. Since rapid 302 
intervention with 670 nm light treatment prevented such statistically significant alterations in 303 
the dendritic morphology for up to 16 hours ex vivo, it is possible that it may prevent or slow 304 
down the changes to the dendrites associated with the pathology of the said neurodegenerative 305 
diseases.  306 
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FIGURE CAPTIONS 468 
Figure 1: The effect of time ex vivo (indicated in the graph legends) on the Sholl profiles of 469 
sham (C) and light (D)-treated RGCs. Stars and daggers indicate statistically significant 470 
reduction in the number of dendritic intersections, from 40 minutes to 8 hours and 16 hours, 471 
respectively. To facilitate comparisons, Sholl profiles of RGCs from sham- and light-treated 472 
retinas are shown at 40 minutes (A) and 16 hours (B) ex vivo. * p<0.05, ** p<0.01, † p<0.05, 473 
†† p<0.01; Mann-Whitney U test. Error bars represent SEM. 474 
Figure 2: The effect of time ex vivo, up to 16 hours, on the average area under the fitted 475 
curves (B) and average maximum Sholl peaks (C) of sham and light treated RGCs. Stars 476 
placed below means indicate statistically significant reductions from the value at 40 minutes, 477 
in RGCs from sham-treated retinae. p values placed above the means correspond to statistical 478 
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comparisons made between light-treated RGCs. p values placed next to the means correspond  479 
to statistical comparisons made between sham and light-treated RGCs at each time point. (A) 480 
A Weibull, 5 parameter curve was fitted to the Sholl data of each individual RGC. Inset: the 481 
equation used to create the curve. * p<0.05, ** p<0.01; Mann-Whitney U test. Error bars 482 
represent SEM. 483 
Figure 3: The effect of time ex vivo, up to 16 hours, on the initial rate of branching of RGC 484 
dendrites (A) and the rate of decay of the Sholl curve (B). p values placed below the means 485 
relate to statistical comparisons made between sham-treated RGCs. p values placed above the 486 
means correspond to statistical comparisons made between light-treated RGCs. p values placed 487 
next to the means correspond to statistical comparisons made between sham and light-treated 488 
RGCs at each time point. Mann-Whitney U test. Error bars represent SEM. 489 
Figure 4: The effect of time ex vivo, up to 16 hours, on the average dendritic field area of 490 
light and sham treated RGCs. (A) The Z-projected image of an RGC showing the dendritic 491 
field area measurement using a polygon tool in ImageJ. Stars placed below the means indicate 492 
statistically significant reductions from the value at 40 minutes, in RGCs from sham-treated 493 
retinae. Stars and p values placed above the means correspond to statistical comparisons made 494 
between light-treated RGCs. p values placed next to the means correspond to statistical 495 
comparisons made between sham and light-treated RGCs at each time point.. * p<0.01; Mann-496 
Whitney U test. Error bars represent SEM. Arrow indicates the axon. Scale bar represents 100 497 
µm.  498 
 25 
Figure 5: The effect of time ex vivo, up to 16 hours, on the average dendritic field length of 499 
RGCs from sham and light treated retinae. (A) A 3-D image of an RGC tracing used to 500 
calculate dendritic field length measurements. (B) Stars placed below the means indicate 501 
statistically significant reductions from the value at 40 minutes, in RGCs from sham-treated 502 
retinae. p values placed above the means correspond to statistical comparisons made between 503 
light-treated RGCs. p values placed next to the means correspond to statistical comparisons 504 
made between sham and light-treated RGCs at each time point. * p<0.01, ** p<0.01; Mann-505 
Whitney U test. Error bars represent SEM. Arrow indicates the axon.  506 
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